The brain injury in the premature born infant: stem cell regeneration research network ( PREMSTEM ) is holding its final conference from 13 to 15 May 2025. The meeting will take place in Hotel SB Diagonal Zero in the Poblenou area of Barcelona, Spain.
Since 2020, PREMSTEM has been focused on investigating human mesenchymal stem cells from donated umbilical cord tissue as a potential therapy to treat brain injury related to preterm birth. Now in the final year of the project, the consortium invites medical professionals, members of the scientific community, policy makers, professionals working in regulatory bodies, and parent and patient associations to hear the latest research related to improving outcomes for children and families affected by brain injury.
Keynote speaker
Associate Professor Atul Malhotra, a senior neonatologist at Monash Children’s Hospital, and a research academic in the Department of Paediatrics at Monash University in Melbourne, Australia will talk about his experience of bringing a stem cell-based therapy to the clinic: the pitfalls, the lessons learned and the successes during his keynote address. Atul is the Principal Investigator of three ongoing umbilical cord blood-derived cell therapy trials.
Session topics
Visit the conference website for more information: https://www.premstem.eu/premstem-conference-2025/
Register to attend in person or online via Eventbrite: https://premstem-conference.eventbrite.es/
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874721.